Abstract
Schizophrenia is a heterogeneous and multifactorial disorder that affects around 21 million people worldwide. The disease is often characterized by the occurrence of positive, negative and cognitive symptoms. Several studies have shown that patients with schizophrenia present high concentrations of inflammatory molecules in the brain. These molecules could cross the blood brain barrier an…